Article

Even ophthalmologists have difficulty spelling it sometimes

Author(s):

Jon Carter

Read the latest Optic Relief from OT cartoonist Jon Carter.

 

© Jon Carter 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Eric D. Donnenfeld, MD, on the effect of lifitegrast clinical signs and biomarkers in dry eye disease
(Image credit: Ophthalmology Times) The Residency Report: Clinical insights from the iStent infinite trial
(Image credit: Ophthalmology Times) ASCRS 2025: Amar Shah, MD, on why hyperosmolar tear film before and after cataract surgery matters
Related Content
Q&A: Dilraj S. Grewal, MD, FASRS, on therapeutics for non-infectious uveitis
May 30th 2025

Q&A: Dilraj S. Grewal, MD, FASRS, on therapeutics for non-infectious uveitis

Patient-Centered Treatment Strategies in the Management of nAMD and DME
May 30th 2025

Patient-Centered Treatment Strategies in the Management of nAMD and DME

Post hoc analysis of GATHER1 and GATHER2 data
May 30th 2025

Post hoc analysis of GATHER1 and GATHER2 data

3 Things You Should Know About Early Treatment Intervention for TED
May 30th 2025

3 Things You Should Know About Early Treatment Intervention for TED

Q&A: Sunir Garg, MD, shares insights on using chlorhexidine for anti-sepsis
May 29th 2025

Q&A: Sunir Garg, MD, shares insights on using chlorhexidine for anti-sepsis

FDA approves Alcon’s Tryptyr (AR-15512) for signs and symptoms of dry eye disease
May 29th 2025

FDA approves Alcon’s Tryptyr (AR-15512) for signs and symptoms of dry eye disease

© 2025 MJH Life Sciences

All rights reserved.